platinum has been researched along with Carcinoma, Adenosquamous in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, Y; Chen, H; Gao, Z; Han, B; Jiang, G; Li, X; Lu, D; Qian, J; Su, B; Tan, X; Wang, J; Wang, S; Wu, Q; Yang, Y; Zhao, X | 1 |
De Souza, AL; Saif, MW | 2 |
Crysandt, M; Esser, A; Jost, E; Osieka, R; von Hobe, S; Wilop, S | 1 |
Hamana, S; Ku, Y; Maruo, T; Miyahara, Y; Motoyama, S; Takeuchi, S; Tateiwa, Y; Yoshida, S | 1 |
1 trial(s) available for platinum and Carcinoma, Adenosquamous
Article | Year |
---|---|
Super high-dose intraarterial cisplatin infusion under percutaneous pelvic perfusion with extracorporeal chemofiltration for advanced uterine cervical carcinoma: I. Analysis for pharmacokinetics, tumor response, and toxicity of platinum.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Feasibility Studies; Female; Humans; Infusions, Intra-Arterial; Middle Aged; Neoplasm Staging; Platinum; Uterine Neoplasms | 2001 |
4 other study(ies) available for platinum and Carcinoma, Adenosquamous
Article | Year |
---|---|
Novel association between CD74 polymorphisms and hematologic toxicity in patients with NSCLC after platinum-based chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antigens, Differentiation, B-Lymphocyte; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Adenosquamous; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; DNA, Neoplasm; Female; Follow-Up Studies; Gastrointestinal Diseases; Genotype; Haplotypes; Hematologic Diseases; Histocompatibility Antigens Class II; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Platinum; Polymorphism, Single Nucleotide; Prognosis | 2014 |
Platinum-based therapy in adenosquamous pancreatic cancer: experience at two institutions.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Cisplatin; Humans; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms; Platinum; Treatment Outcome | 2014 |
Squamous cell carcinoma of the pancreas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Humans; Pancreatic Neoplasms; Platinum | 2014 |
Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Carcinoma, Adenosquamous; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Humans; Lung Neoplasms; Male; Middle Aged; Platinum; Prognosis; Retrospective Studies; Survival Rate | 2009 |